
Liquidity, historical trends, and peer comparisons.
According to RemeGen Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 4.94. This represents a change of 54.27% compared to the average of 3.20 of the last 4 quarters.
The mean historical Current Ratio of RemeGen Co., Ltd. over the last ten years is 2.36. The current 4.94 Current Ratio has changed 109.28% with respect to the historical average. Over the past ten years (40 quarters), REGMF's Current Ratio was at its highest in in the March 2022 quarter at 7.48. The Current Ratio was at its lowest in in the March 2019 quarter at 0.
Average
2.36
Median
1.69
Minimum
0.07
Maximum
6.90
Discovering the peaks and valleys of RemeGen Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 4.20%
Maximum Annual Current Ratio = 6.90
Minimum Annual Increase = -46.59%
Minimum Annual Current Ratio = 0.07
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 1.43 | 36.51% |
| 2024 | 1.05 | -46.59% |
| 2023 | 1.96 | -45.57% |
| 2022 | 3.60 | -3.52% |
| 2021 | 3.73 | -45.95% |
| 2020 | 6.90 | 4.20% |
| 2019 | 0.16 | 146.67% |
The current Current Ratio of RemeGen Co., Ltd. (REGMF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.48
5-year avg
2.35
10-year avg
2.36
RemeGen Co., Ltd.’s Current Ratio is greater than BeOne Medicines Ltd. Class A (3.40), greater than Shanghai Junshi Biosciences Co., Ltd. (2.05), less than Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (19.96), greater than Shanghai Allist Pharmaceuticals Co., Ltd. (4.60), less than Jiangsu Hengrui Medicine Co., Ltd. (7.91), greater than Sichuan Kelun Pharmaceutical Co., Ltd. Class A (2.45), greater than Suzhou Zelgen Biopharmaceuticals Co., Ltd. (2.58), greater than Mabwell (Shanghai) Bioscience Co., Ltd. (1.53), less than Evopoint Biosciences Co. Ltd. (0),
| Company | Current Ratio | Market cap |
|---|---|---|
| 3.40 | $275.98B | |
| 2.05 | $23.75B | |
| 19.96 | $29.49B | |
| 4.60 | $38.70B | |
| 7.91 | $312.89B | |
| 2.45 | $69.17B | |
| 2.58 | $24.13B | |
| 1.53 | $8.60B | |
| 0 | $19.09B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RemeGen Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like RemeGen Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is RemeGen Co., Ltd.'s Current Ratio?
How is the Current Ratio calculated for RemeGen Co., Ltd. (REGMF)?
What is the highest Current Ratio for RemeGen Co., Ltd. (REGMF)?
What is the 3-year average Current Ratio for RemeGen Co., Ltd. (REGMF)?
What is the 5-year average Current Ratio for RemeGen Co., Ltd. (REGMF)?
How does the current Current Ratio for RemeGen Co., Ltd. (REGMF) compare to its historical average?